Back
Product details:
CAS
1346546-69-7
Purity
95%
A RIPK3 inhibitor. GSK-872 decreases the RIPK3-mediated necroptosis and subsequent cytoplasmic translocation and expression of HMGB1, as well as ameliorates brain edema and neurological deficits in early brain injury.
Properties
Name
GSK-872
Smiles
CC(C)S(=O)(=O)C=1C=CC=2NC=CC(=NC=3C=CC=4SC=NC4C3)C2C1
Targets
Please log in to see this information
GSK'872 | GSK’872
No data available
The compound has purity validated by NMR and/or LCMS methods.
1 mg
$19
2 mg
$19
5 mg
$19
10 mg
$19
15 mg
$19
20 mg
$19
25 mg
$19
30 mg
$19
35 mg
$19
40 mg
$19
45 mg
$19
50 mg
$19
75 mg
$19
100 mg
$19
Quantity
1
Total amount
$ 19
GSK'872 | GSK’872
No data available
The compound has purity validated by NMR and/or LCMS methods.
Target activity features
It should be emphasized that the product may be active against a larger number of targets than shown on the card. The information represented here refers to the targets with the largest value of pX or the targets with ΔpX less than 1.5 from the largest pX value.